The endovascular stent grafts market size has grown exponentially in recent years. It will grow from $1.45 billion in 2025 to $1.99 billion in 2026 at a compound annual growth rate (CAGR) of 37.9%. The growth in the historic period can be attributed to reliance on conventional open surgical procedures, limited availability of advanced stent graft materials, growing prevalence of vascular diseases, early adoption of coronary and peripheral grafts, increasing awareness of aortic aneurysm treatments.
The endovascular stent grafts market size is expected to see exponential growth in the next few years. It will grow to $7.13 billion in 2030 at a compound annual growth rate (CAGR) of 37.5%. The growth in the forecast period can be attributed to technological innovations in endovascular stent grafts, rising minimally invasive surgeries, growth in aortic aneurysm and dissection cases, increasing adoption of hybrid vascular grafts, expansion of cardiovascular healthcare infrastructure. Major trends in the forecast period include increasing adoption of minimally invasive endovascular procedures, rising demand for customized stent grafts, advancements in hybrid and biologic graft materials, expansion of thoracic and abdominal aortic repair procedures, enhanced focus on patient safety and regulatory compliance.
The increasing prevalence of cardiovascular diseases is increasingly supporting the expansion of the endovascular stent graft market going forward. Cardiovascular disease refers to a broad category of conditions involving the heart or blood vessels. The rising prevalence of cardiovascular diseases is influenced by lifestyle behaviors, pre-existing medical conditions, genetic predispositions, and environmental factors. Endovascular stent grafts provide an effective treatment option by reinforcing weakened blood vessel walls, reducing rupture risk, and minimizing invasive surgical intervention while improving patient outcomes. For example, in October 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency, an estimated 57,100 adults aged 25 years and older experienced acute coronary events in 2023, averaging approximately 156 cases per day. As a result, the growing prevalence of cardiovascular diseases is strengthening demand within the endovascular stent graft market.
Leading companies operating in the endovascular stent grafts market are focused on developing innovative products such as thoracic aortic stent grafts to improve treatment precision, enhance patient outcomes, and address complex anatomical challenges. A thoracic aortic stent graft is a specialized device used in endovascular surgery to manage diseases of the thoracic aorta by providing a safe and effective minimally invasive treatment option. For example, in February 2024, Endovastec, a China-based medical device company, introduced the Multi-Branch Thoracic Aortic Stent-Graft System (Hector) and completed its first clinical application in Switzerland. The system’s multi-branch design allows treatment of complex thoracic aortic conditions while preserving blood flow to critical arterial branches.
In December 2023, TekniPlex Healthcare Inc., a US-based provider of medical device components, acquired Seisa Medical S.A. de C.V. for an undisclosed amount. Through this acquisition, TekniPlex aims to expand its medical device manufacturing capabilities and strengthen its presence in the Latin American healthcare market. Seisa Medical S.A. de C.V. is a Mexico-based manufacturer specializing in endovascular stent grafts.
Major companies operating in the endovascular stent grafts market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Terumo Corporation, Cook Group Incorporated, Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates Inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc., Endovastec Medical Technology Co Ltd., Jotec GmbH, Bentley InnoMed GmbH, Bolton Medical Inc., Alvimedica, Endospan Ltd., Vivasure Medical Ltd.
North America was the largest region in the endovascular stent grafts market in 2025. The regions covered in the endovascular stent grafts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the endovascular stent grafts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the endovascular stent graft market by increasing costs of imported stent materials, including metal alloys and biologic graft fabrics. Segments like thoracic and abdominal endovascular stent grafts are most impacted, particularly in Asia-Pacific regions such as China and India, which are major production and import hubs. The resulting higher costs and potential supply chain delays have prompted manufacturers to explore local sourcing and production. Positively, tariffs have encouraged investment in domestic manufacturing capabilities and innovation in cost-efficient stent graft solutions.
The endovascular stent grafts market research report is one of a series of new reports that provides endovascular stent grafts market statistics, including endovascular stent grafts industry global market size, regional shares, competitors with a endovascular stent grafts market share, detailed endovascular stent grafts market segments, market trends and opportunities, and any further data you may need to thrive in the endovascular stent grafts industry. This endovascular stent grafts market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Endovascular stent grafts are medical devices used to treat blood vessel problems such as aneurysms or narrowing. They consist of a metal mesh tube covered with a fabric graft and are inserted into the affected vessel through a catheter, usually via a large artery in the groin or arm. These devices repair damaged or weakened vessels and offer a less invasive alternative to open surgery.
The main product categories of endovascular stent grafts include hemodialysis access grafts, endovascular stent grafts, coronary artery bypass grafts, vascular grafts for aortic disease, and peripheral vascular grafts. Hemodialysis access grafts are specialized vascular grafts designed to create access for hemodialysis in patients with renal failure. The raw materials include synthetic vascular grafts, biological vascular grafts, and hybrid vascular grafts, which are used in applications such as cardiac aneurysms, kidney failure, vascular occlusions, and coronary artery diseases.
The endovascular stent grafts market consists of sales of aortoiliac stent grafts, thoracic endograft, and abdominal endografts. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The endovascular stent grafts market size is expected to see exponential growth in the next few years. It will grow to $7.13 billion in 2030 at a compound annual growth rate (CAGR) of 37.5%. The growth in the forecast period can be attributed to technological innovations in endovascular stent grafts, rising minimally invasive surgeries, growth in aortic aneurysm and dissection cases, increasing adoption of hybrid vascular grafts, expansion of cardiovascular healthcare infrastructure. Major trends in the forecast period include increasing adoption of minimally invasive endovascular procedures, rising demand for customized stent grafts, advancements in hybrid and biologic graft materials, expansion of thoracic and abdominal aortic repair procedures, enhanced focus on patient safety and regulatory compliance.
The increasing prevalence of cardiovascular diseases is increasingly supporting the expansion of the endovascular stent graft market going forward. Cardiovascular disease refers to a broad category of conditions involving the heart or blood vessels. The rising prevalence of cardiovascular diseases is influenced by lifestyle behaviors, pre-existing medical conditions, genetic predispositions, and environmental factors. Endovascular stent grafts provide an effective treatment option by reinforcing weakened blood vessel walls, reducing rupture risk, and minimizing invasive surgical intervention while improving patient outcomes. For example, in October 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency, an estimated 57,100 adults aged 25 years and older experienced acute coronary events in 2023, averaging approximately 156 cases per day. As a result, the growing prevalence of cardiovascular diseases is strengthening demand within the endovascular stent graft market.
Leading companies operating in the endovascular stent grafts market are focused on developing innovative products such as thoracic aortic stent grafts to improve treatment precision, enhance patient outcomes, and address complex anatomical challenges. A thoracic aortic stent graft is a specialized device used in endovascular surgery to manage diseases of the thoracic aorta by providing a safe and effective minimally invasive treatment option. For example, in February 2024, Endovastec, a China-based medical device company, introduced the Multi-Branch Thoracic Aortic Stent-Graft System (Hector) and completed its first clinical application in Switzerland. The system’s multi-branch design allows treatment of complex thoracic aortic conditions while preserving blood flow to critical arterial branches.
In December 2023, TekniPlex Healthcare Inc., a US-based provider of medical device components, acquired Seisa Medical S.A. de C.V. for an undisclosed amount. Through this acquisition, TekniPlex aims to expand its medical device manufacturing capabilities and strengthen its presence in the Latin American healthcare market. Seisa Medical S.A. de C.V. is a Mexico-based manufacturer specializing in endovascular stent grafts.
Major companies operating in the endovascular stent grafts market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Terumo Corporation, Cook Group Incorporated, Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates Inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc., Endovastec Medical Technology Co Ltd., Jotec GmbH, Bentley InnoMed GmbH, Bolton Medical Inc., Alvimedica, Endospan Ltd., Vivasure Medical Ltd.
North America was the largest region in the endovascular stent grafts market in 2025. The regions covered in the endovascular stent grafts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the endovascular stent grafts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the endovascular stent graft market by increasing costs of imported stent materials, including metal alloys and biologic graft fabrics. Segments like thoracic and abdominal endovascular stent grafts are most impacted, particularly in Asia-Pacific regions such as China and India, which are major production and import hubs. The resulting higher costs and potential supply chain delays have prompted manufacturers to explore local sourcing and production. Positively, tariffs have encouraged investment in domestic manufacturing capabilities and innovation in cost-efficient stent graft solutions.
The endovascular stent grafts market research report is one of a series of new reports that provides endovascular stent grafts market statistics, including endovascular stent grafts industry global market size, regional shares, competitors with a endovascular stent grafts market share, detailed endovascular stent grafts market segments, market trends and opportunities, and any further data you may need to thrive in the endovascular stent grafts industry. This endovascular stent grafts market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Endovascular stent grafts are medical devices used to treat blood vessel problems such as aneurysms or narrowing. They consist of a metal mesh tube covered with a fabric graft and are inserted into the affected vessel through a catheter, usually via a large artery in the groin or arm. These devices repair damaged or weakened vessels and offer a less invasive alternative to open surgery.
The main product categories of endovascular stent grafts include hemodialysis access grafts, endovascular stent grafts, coronary artery bypass grafts, vascular grafts for aortic disease, and peripheral vascular grafts. Hemodialysis access grafts are specialized vascular grafts designed to create access for hemodialysis in patients with renal failure. The raw materials include synthetic vascular grafts, biological vascular grafts, and hybrid vascular grafts, which are used in applications such as cardiac aneurysms, kidney failure, vascular occlusions, and coronary artery diseases.
The endovascular stent grafts market consists of sales of aortoiliac stent grafts, thoracic endograft, and abdominal endografts. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Endovascular Stent Grafts Market Characteristics
3. Endovascular Stent Grafts Market Supply Chain Analysis
4. Global Endovascular Stent Grafts Market Trends and Strategies
5. Endovascular Stent Grafts Market Analysis of End Use Industries
7. Global Endovascular Stent Grafts Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Endovascular Stent Grafts Total Addressable Market (TAM) Analysis for the Market
9. Endovascular Stent Grafts Market Segmentation
10. Endovascular Stent Grafts Market Regional and Country Analysis
11. Asia-Pacific Endovascular Stent Grafts Market
12. China Endovascular Stent Grafts Market
13. India Endovascular Stent Grafts Market
14. Japan Endovascular Stent Grafts Market
15. Australia Endovascular Stent Grafts Market
16. Indonesia Endovascular Stent Grafts Market
17. South Korea Endovascular Stent Grafts Market
18. Taiwan Endovascular Stent Grafts Market
19. South East Asia Endovascular Stent Grafts Market
20. Western Europe Endovascular Stent Grafts Market
21. UK Endovascular Stent Grafts Market
22. Germany Endovascular Stent Grafts Market
23. France Endovascular Stent Grafts Market
24. Italy Endovascular Stent Grafts Market
25. Spain Endovascular Stent Grafts Market
26. Eastern Europe Endovascular Stent Grafts Market
27. Russia Endovascular Stent Grafts Market
28. North America Endovascular Stent Grafts Market
29. USA Endovascular Stent Grafts Market
30. Canada Endovascular Stent Grafts Market
31. South America Endovascular Stent Grafts Market
32. Brazil Endovascular Stent Grafts Market
33. Middle East Endovascular Stent Grafts Market
34. Africa Endovascular Stent Grafts Market
36. Endovascular Stent Grafts Market Competitive Landscape and Company Profiles
37. Endovascular Stent Grafts Market Other Major and Innovative Companies
40. Endovascular Stent Grafts Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Endovascular Stent Grafts Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses endovascular stent grafts market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for endovascular stent grafts? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The endovascular stent grafts market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Hemodialysis Access Grafts; Endovascular Stent Grafts; Coronary Artery By-Pass Grafts; Vascular Grafts For Aorta Disease; Peripheral Vascular Grafts2) By Raw Material: Synthetic Vascular Grafts; Biological Vascular Grafts; Hybrid Vascular Grafts
3) By Application: Cardiac Aneurysm; Kidney Failure; Vascular Occlusion; Coronary Artery Disease
Subsegments:
1) By Hemodialysis Access Grafts: Arteriovenous (AV) Fistula Grafts; Synthetic Hemodialysis Access Grafts; Bioengineered Hemodialysis Access Grafts; Coated Hemodialysis Grafts; Endovascular Hemodialysis Grafts2) By Endovascular Stent Grafts: Aneurysm Stent Grafts; Stent Grafts For Aortic Dissection; Thoracic Endovascular Stent Grafts; Abdominal Endovascular Stent Grafts; Biliary Endovascular Stent Grafts
3) By Coronary Artery By-Pass Grafts: Saphenous Vein Grafts (SVG); Arterial Coronary Bypass Grafts; Endovascular Coronary Artery Bypass Grafts (CABG); Synthetic Coronary Bypass Grafts
4) By Vascular Grafts For Aorta Disease: Endovascular Aortic Stent Grafts; Aortic Aneurysm Grafts; Aortic Bypass Grafts; Thoracoabdominal Aortic Stent Grafts; Aortic Dissection Stent Grafts
5) By Peripheral Vascular Grafts: Carotid Artery Stent Grafts; Femoral Artery Stent Grafts; Popliteal Artery Stent Grafts; Iliac Artery Stent Grafts; Peripheral Endovascular Stent Grafts
Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; Terumo Corporation; Cook Group Incorporated; Merit Medical Systems Inc.; Biotronik SE & Co KG; MicroPort Scientific Corporation; Endologix LLC; LeMaitre Vascular Inc.; Lifetech Scientific Corporation; W. L. Gore & Associates Inc.; Braile Biomedica; BrosMed Medical BV; Micro Interventional Devices Inc. (MID); Lombard Medical Inc.; Endovastec Medical Technology Co Ltd.; Jotec GmbH; Bentley InnoMed GmbH; Bolton Medical Inc.; Alvimedica; Endospan Ltd.; Vivasure Medical Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Endovascular Stent Grafts market report include:- Abbott Laboratories
- Medtronic PLC
- Boston Scientific Corporation
- Terumo Corporation
- Cook Group Incorporated
- Merit Medical Systems Inc.
- Biotronik SE & Co KG
- MicroPort Scientific Corporation
- Endologix LLC
- LeMaitre Vascular Inc.
- Lifetech Scientific Corporation
- W. L. Gore & Associates Inc.
- Braile Biomedica
- BrosMed Medical BV
- Micro Interventional Devices Inc. (MID)
- Lombard Medical Inc.
- Endovastec Medical Technology Co Ltd.
- Jotec GmbH
- Bentley InnoMed GmbH
- Bolton Medical Inc.
- Alvimedica
- Endospan Ltd.
- Vivasure Medical Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.99 Billion |
| Forecasted Market Value ( USD | $ 7.13 Billion |
| Compound Annual Growth Rate | 37.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
